INTA vs SRPT · rev $577.8M vs rev $1.90B
Intapp Inc (INTA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Intapp Inc (INTA) is a software - application company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported INTA revenue for 2026-06-30 was $577.8M. Net income was -$41.3M. Revenue was up 14.6% from 2025-06-30 to 2026-06-30. INTA currently screens at market cap $3.89B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
INTA currently screens at market cap $3.89B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the INTA and SRPT stock pages for the full models.
Not investment advice.